H2 receptor antagonists vs placebo or no prophylaxis
Blood transfusion · people admitted to intensive care units
H2 receptor antagonists probably leads to lower number of participants requiring blood transfusions compared with placebo or no prophylaxis (moderate certainty).
1 finding from 1 review
- Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units 2018 · Cochrane Headline outcomes onlyRR 0.58 [0.36, 0.95]7 studies · 655 participantsModerate